SALT LAKE CITY, UT / ACCESSWIRE / June 4, 2024 / KindlyMD, Inc. (NASDAQ:KDLY) (NASDAQ:KDLYW) ("KindlyMD" or "the Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced that Tim Pickett, Founder and Chief Executive Officer, is scheduled to present at the KCSA Cannabis Virtual Conference on Wednesday, June 5th at 3 p.m. ET.
Registration Link: https://bit.ly/3QVIu08
If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available.
To schedule a one-on-one meeting with the Company's management team, please email KCSA Strategic Communications at This email address is being protected from spambots. You need JavaScript enabled to view it..
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
About KindlyMD
KindlyMD™️ is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.
For more information, please visit www.kindlymd.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Learn more about the event at www.virtualinvestorconferences.com.
Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$24.94 |
Daily Volume: | 0 |
Market Cap: | US$149.140M |
January 22, 2025 November 13, 2024 October 29, 2024 October 08, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load